Dr. Onno van de Stolpe is a Chief Executive Officer at Galapagos NV. He is on the Board of Directors at Galapagos Biotech Ltd., Institute For Human Organ & Disease Model Technologies and Leyden Laboratories B.V. Dr. van de Stolpe was previously employed as a Chief Executive Officer by Galapagos Genomics NV, a Managing Director-Genomics Division by Introgene BV, a Member-Supervisory Board by DCPrime BV, a Manager-Business Development by Mogen International Nv, a Managing Director by Molecular Probes Europe BV, a Managing Director by Molecular Probes, Inc., and a Principal by Netherlands Foreign Investment Agency. He also served on the board at European Biotech Acquisition Corp. He received his graduate degree from Wageningen University.